Skip to main content
. 2024 Feb 20;17(3):267. doi: 10.3390/ph17030267

Figure 2.

Figure 2

Potential targets for TGF-β inhibition. Different levels of inhibiting TGF-β-induced fibrosis with some examples of therapeutic strategies, including the inhibition of activation of latent TGF-β by integrins or proteases, the direct blockade of TGF-β by neutralizing antibodies and soluble TβRII, inhibitors of ALK (also termed TβRI), and the inhibition of signaling pathways. Figure created by Vistnes.